In the subgroup of RA patients who received biologic therapy, a significant correlation was observed between sICAM-1 level and IgM antibodies against HpmB, which suggests the triggering of RA by P. mirabilis. This evidence concerns the gene CD40LG and rheumatoid arthritis.